• Share
  • Email
  • Print

Neil Miller

Special Counsel
Fax +61.3.9205.2055

Mr. Miller has a wealth of experience acting for a broad range of listed public and private companies, locally and internationally.

His main areas of expertise include mergers and acquisitions, private equity transactions, various capital raisings for listed and unlisted companies (including IPO, rights issue, convertible notes and bonds, placements and associated underwritings), corporate restructuring (including schemes of arrangement, capital reductions, share buy backs), employee incentive and share purchase plans, extraordinary and annual general meeting documentation and advising on Corporations Act and ASX compliance.

His practice includes advising many clients in the technology and life sciences sectors, including many start up or early stage companies concerning local and international cross border transactions.

  • Managing initial public offerings (IPO) and ASX Listings for Allomak Limited, EvoGenix Ltd, Mesoblast Limited, Octagonal Resources Limited, Patrys Limited, and TSV Holdings Limited.
  • Acting on the US$350 million acquisition of 20% stake in Mesoblast Ltd (and US$1.7 billion strategic alliance/milestone payments) with US Listed Cephalon Inc. (now Teva Pharmaceutical Industries Ltd).
  • Conducting the Scheme of Arrangement of Keycorp Limited by private equity group Archer Capital.
  • Acting on an ASX Listed company demerger/capital distribution and subsequent listing of the spin off entity in Singapore.
  • Acting on several multiple State company and business mergers/consolidations leading to its IPO and ASX Listing (for example, TSV Holdings Limited and Allomak Limited).
  • Advising and negotiating overseas equity funding arrangements for Australian listed companies (including drafting documents for capital investment in the United States by local companies, overseas investors subscribing locally and underwritings generally).
  • Documenting share buy backs, capital reductions, rights issues, employee share plans, share purchase plans, convertible notes and bonds, underwriting and other capital raising documents for private and public companies.
  • Producing complex public company extraordinary general meeting and annual general meeting documentation and information memoranda.